Endoscopic ultrasound in patients with resectable perihilar cholangiocarcinoma: impact on clinical decision-making
Endoscopy International Open · 2023-02 · 11 (02) · E162-E168
DOI: 10.1055/a-2005-3679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, online erschienen am 02.02.2023. Verfasst von David M de Jong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Erasmus MC Cancer Institute University Medical Center Rotterdam, Department of Gastroenterology and Hepatology, Rotterdam, Netherlands. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and study aims Accurate assessment of the lymph node (LN) status is crucial in resectable perihilar cholangiocarcinoma (pCCA) to prevent major surgery in patients with extraregional metastatic LNs (MLNs). This study investigates the added value of preoperative endoscopic ultrasound (EUS) with or without tissue acquisition (TA) for the detection of MLNs in patients with resectable pCCA. Patients and methods In this retrospective, multicenter cohort study, patients with potentially resectable pCCA who underwent EUS preoperatively between 2010–2020, were included. The clinical impact of EUS-TA was defined as the percentage of patients who did not undergo surgical resection due to MLNs found with EUS-TA. Findings of cross-sectional imaging were compared with EUS-TA findings and surgery.
Results
EUS was performed on 141 patients, of whom 107 (76 %) had suspicious LNs on cross-sectional imaging. Surgical exploration was prevented in 20 patients (14 %) because EUS-TA detected MLNs, of which 17 (85 %) were extraregional. Finally, 74 patients (52 %) underwent surgical exploration followed by complete resection in 40 (28 %). MLNs were identified at definitive pathology in 24 (33 %) patients, of which 9 (38 %) were extraregional and 15 (63 %) regional.
Conclusions
EUS-TA may be of value in patients with potentially resectable pCCA based on preoperative cross-sectional imaging, regardless of lymphadenopathy at cross-sectional imaging. A prospective study in which a comprehensive EUS investigation with LN assessment and EUS-TA of LNs is performed routinely should confirm this promise.
Autor:innen und Institutionen
- Erasmus MC Cancer Institute University Medical Center Rotterdam, Department of Gastroenterology and Hepatology, Rotterdam, Netherlands.
- Erasmus MC Cancer Institute University Medical Center Rotterdam, Department of Radiology and Nuclear Medicine, Rotterdam, Netherlands.
- Erasmus MC Cancer Institute University Medical Center Rotterdam, Department of Pathology, Rotterdam, Netherlands.
- Amsterdam University Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, Netherlands.
- Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, Netherlands.
- Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, Netherlands.
Zitieren
APA
de Jong, D. M., van de Vondervoort, S., Dwarkasing, R. S., Doukas, M., Voermans, R. P., Verdonk, R. C., Polak, W. G., de Jonge, J., Koerkamp, B. G., Bruno, M. J., & van Driel, L. M. J. W. (2023). Endoscopic ultrasound in patients with resectable perihilar cholangiocarcinoma: impact on clinical decision-making. Endoscopy International Open, 11(02), E162-E168. https://doi.org/10.1055/a-2005-3679
Vancouver
de Jong DM, van de Vondervoort S, Dwarkasing RS, Doukas M, Voermans RP, Verdonk RC, et al. Endoscopic ultrasound in patients with resectable perihilar cholangiocarcinoma: impact on clinical decision-making. Endoscopy International Open. 2023;11(02):E162-E168. doi:10.1055/a-2005-3679
BibTeX
@article{deJong2023,
author = {de Jong, David M and van de Vondervoort, Sanne and Dwarkasing, Roy S and Doukas, Michael and Voermans, Rogier P and Verdonk, Robert C and Polak, Wojciech G and de Jonge, Jeroen and Koerkamp, Bas Groot and Bruno, Marco J and van Driel, Lydi M J W},
title = {Endoscopic ultrasound in patients with resectable perihilar cholangiocarcinoma: impact on clinical decision-making},
journal = {Endoscopy International Open},
year = {2023},
volume = {11},
number = {02},
pages = {E162--E168},
doi = {10.1055/a-2005-3679}
}
EUVIMED